down arrow

Ben Tre Pharmaceutical JSC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DBT6
VND
11,350.00
-50 (-0.44%)

Dec 12

STC

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Net Sales
1,61,230.72
2,58,393.55
2,00,555.87
2,24,091.88
1,85,370.29
2,46,121.00
1,89,198.83
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,61,230.72
2,58,393.55
2,00,555.87
2,24,091.88
1,85,370.29
2,46,121.00
1,89,198.83
Raw Material Cost
86,315.01
1,51,927.38
1,30,033.14
1,40,608.79
1,11,894.81
1,50,847.50
1,17,689.93
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
41,520.02
0.00
35,536.62
43,975.75
37,835.32
0.00
34,911.11
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10,256.98
10,146.96
9,888.31
10,166.80
9,927.57
10,653.95
10,657.43
Selling and Distribution Expenses
62,155.01
91,297.33
61,384.33
71,177.47
61,797.56
76,249.57
59,915.28
Other Expenses
-5,177.70
-1,014.70
-4,542.49
-5,414.26
-4,776.29
-1,065.39
-4,556.85
Total Expenditure (Excl Depreciation)
1,48,470.02
2,43,224.71
1,91,417.47
2,11,786.26
1,73,692.37
2,27,097.08
1,77,605.21
Operating Profit (PBDIT) excl Other Income
12760.699999999999
15168.800000000001
9138.4
12305.599999999999
11677.9
19023.9
11593.599999999999
Other Income
759.15
787.19
2,653.11
1,197.96
6,763.42
17.40
715.55
Operating Profit (PBDIT)
18,135.61
20,811.97
15,342.59
16,914.59
23,592.96
21,347.03
14,587.64
Interest
10,256.98
10,146.96
9,888.31
10,166.80
9,927.57
10,653.95
10,657.43
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
74,915.71
1,06,466.17
70,522.74
83,483.08
73,475.48
95,273.50
71,508.89
Depreciation
4,615.75
4,855.94
3,551.07
3,411.02
5,151.63
2,305.71
2,278.48
Profit Before Tax
3,262.88
5,809.07
1,903.20
3,336.78
8,513.77
8,387.37
1,651.73
Tax
1,219.17
1,230.88
1,341.12
1,943.01
2,406.56
1,223.50
1,036.43
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,655.74
4,260.14
2,033.22
927.89
7,396.15
6,237.52
709.08
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,655.74
4,260.14
2,033.22
927.89
7,396.15
6,237.52
709.08
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-612.04
318.06
-1,471.13
465.87
-1,288.94
926.36
-93.78
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,043.71
4,578.20
562.08
1,393.77
6,107.21
7,163.88
615.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
2,68,100.09
2,65,444.35
2,39,059.09
2,55,089.95
2,47,252.08
2,39,916.08
2,33,635.24
Earnings per share (EPS)
129.36
207.5
109.25
49.86
397.41
335.15
38.1
Diluted Earnings per share
129.36
207.5
109.25
49.86
397.41
335.15
38.1
Operating Profit Margin (Excl OI)
7.91%
5.87%
4.56%
5.49%
6.3%
7.73%
6.13%
Gross Profit Margin
4.89%
4.13%
2.72%
3.01%
7.37%
4.34%
2.08%
PAT Margin
1.65%
1.65%
1.01%
0.41%
3.99%
2.53%
0.37%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2025 is -13.02% vs 6.75% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2025 is -66.54% vs -39.32% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2025 is 3.25% vs -24.47% in Mar 2024

stock-summary

Interest

YoY Growth in quarter ended Mar 2025 is 3.32% vs 6.42% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2025 has improved from Mar 2024

Compare Quarterly Results Of Ben Tre Pharmaceutical JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
1,61,230.72
2,29,661.57
-68,430.85
-29.80%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,61,230.72
2,29,661.57
-68,430.85
-29.80%
Raw Material Cost
86,315.01
1,79,586.37
-93,271.36
-51.94%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
41,520.02
31,261.21
10,258.81
32.82%
Power Cost
0
0
0.00
Manufacturing Expenses
10,256.98
0.00
10,256.98
Selling and Distribution Expenses
62,155.01
58,059.67
4,095.34
7.05%
Other Expenses
-5,177.70
-3,126.12
-2,051.58
-65.63%
Total Expenditure (Excl Depreciation)
1,48,470.02
2,37,646.04
-89,176.02
-37.52%
Operating Profit (PBDIT) excl Other Income
12,760.70
-7,984.47
20,745.17
259.82%
Other Income
759.15
1,249.89
-490.74
-39.26%
Operating Profit (PBDIT)
18,135.61
-1,678.51
19,814.12
1,180.46%
Interest
10,256.98
0.00
10,256.98
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
74,915.71
50,075.20
24,840.51
49.61%
Depreciation
4,615.75
11,774.08
-7,158.33
-60.80%
Profit Before Tax
3,262.88
-13,452.59
16,715.47
124.25%
Tax
1,219.17
0.00
1,219.17
Provisions and contingencies
0
0
0.00
Profit After Tax
2,655.74
-13,452.59
16,108.33
119.74%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,655.74
-13,452.59
16,108.33
119.74%
Share in Profit of Associates
0
0
0.00
Minority Interest
-612.04
0.00
-612.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,043.71
-13,452.59
15,496.30
115.19%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
2,68,100.09
12,71,231.42
-10,03,131.33
-78.91%
Earnings per share (EPS)
129.36
-532.39
661.75
124.30%
Diluted Earnings per share
129.36
-532.39
661.75
124.30%
Operating Profit Margin (Excl OI)
7.91%
-6.40%
0.00
14.31%
Gross Profit Margin
4.89%
-0.73%
0.00
5.62%
PAT Margin
1.65%
-5.86%
0.00
7.51%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 16,123.07 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -37.60% vs 28.84% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is -13.02% vs 6.75% in Mar 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 204.37 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -55.36% vs 714.48% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is -66.54% vs -39.32% in Mar 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,737.65 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -13.23% vs 57.81% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 3.25% vs -24.47% in Mar 2024

Quarterly - Interest
Interest 1,025.70 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 1.08% vs 2.62% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 3.32% vs 6.42% in Mar 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.91%
in Mar 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 has improved from Mar 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."